Venlafaxine in Children, Adolescents, and Young Adults With Autism Spectrum Disorders: An Open Retrospective Clinical Report

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Child Neurology

• Publication date

  2000-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/088307380001500214PMID 10695900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients.

  1998cited by this paper
• A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

  1998cited by this paper
• Sertraline Treatment of Transition-Associated Anxiety and Agitation in Children with Autistic Disorder

  1997cited by this paper
• Effects of tryptophan depletion in drug-free adults with autistic disorder.

  1996cited by this paper
• Treatment of obsessive-compulsive disorder with venlafaxine.

  1996cited by this paper
• Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases.

  1996cited by this paper
• Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives.

  1996cited by this paper
• A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

  1996cited by this paper
• A pilot study of clomipramine in young autistic children.

  1996cited by this paper
• The Safety and Tolerability of Venlafaxine Hydrochloride: Analysis of the Clinical Trials Database

  1996cited by this paper
• Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial.

  1996cited by this paper
• Dose-Response Relationship With Venlafaxine

  1996cited by this paper
• Venlafaxine in social phobia.

  1995cited by this paper
• Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder.

  1994cited by this paper
• A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

  1993cited by this paper
• Fluoxetine treatment of children and adults with autistic disorder and mental retardation.

  1992cited by this paper
• Platelet serotonin, a possible marker for familial autism

  1991cited by this paper
• Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.

  1984cited by this paper

• Available Treatments for Autism Spectrum Disorder: From Old Strategies to New Options

  2025cites this paper
• Exploring pathological targets and advancing pharmacotherapy in autism spectrum disorder: Contributions of glial cells and heavy metals.

  2025cites this paper
• Case Report: Methylphenidate and venlafaxine improved abdominal nociplastic pain in an adult patient with attention deficit hyperactivity disorder, autism spectrum disorder, and comorbid major depression

  2024cites this paper
• Review of pharmacogenomics of psychiatric comorbidities in autism spectrum disorder.

  2023cites this paper
• Pharmacotherapy for bipolar disorder in adults with high-functioning autism

  2022cites this paper
• Venlafaxine

  2021cites this paper
• The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.

  2021cites this paper
• Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review

  2020influential citation
• Psychopharmacology of Autism Spectrum Disorder

  2020cites this paper
• Mood Disorders

  2020cites this paper
• The psychopharmacology of autism spectrum disorder and Rett syndrome.

  2019cites this paper
• Visuo-perceptual correlates of autistic trait expression in children with Fragile X syndrome and Down Syndrome

  2019cites this paper
• Evoking subclinical hypomania as a potential autism treatment - a hypothesis based on an up-to-date literature review

  2018cites this paper
• 57 – Autistic Spectrum Disorders

  2017cites this paper
• Psychopharmacologic intervention for adults with autism spectrum disorder: A systematic literature review

  2016cites this paper
• Using venlafaxine to treat behavioral disorders in patients with autism spectrum disorder.

  2016cites this paper
• Treatment of Autism Spectrum Disorder in Children and Adolescents.

  2016cites this paper
• Mood and anxiety problems in young people with ASD : focus on measurement and neurophysiological mechanisms

  2016cites this paper
• Low Doses of Venlafaxine in a Young Man with ASD and Behavioral Disorders: A Case Report

  2016cites this paper
• Update on psychopharmacology for autism spectrum disorders

  2016cites this paper
• Psychotropic Treatment of Autism

  2015cites this paper
• Pupillometry Reveals a Mechanism for the Autism Spectrum Disorder (ASD) Advantage in Visual Tasks

  2014cites this paper
• Autismo: entre a alta sistematização e a baixa empatia. Um estudo sobre a hipótese de hiper masculinização do cérebro no espectro autista

  2014cites this paper
• Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial

  2013influential citation
• The Mechanisms Underlying the ASD Advantage in Visual Search

  2013cites this paper
• Anxiety in Children with Autism Spectrum Disorder

  2013cites this paper
• Current state and future prospects of pharmacological interventions for autism

  2013cites this paper
• Current Trends in the Pharmacological Treatment of Autism Spectrum Disorders

  2013cites this paper
• Treatment of Cataplexy in a Three-Year-Old Using Venlafaxine

  2013cites this paper
• Researching the Autism Spectrum: Contemporary Perspectives

  2013cites this paper
• Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials.

  2013cites this paper
• Trends, Correlates, and Disease Patterns of Antidepressant Use Among Children and Adolescents in Taiwan

  2013cites this paper
• Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan

  2012cites this paper
• Pharmacotherapy to control behavioral symptoms in children with autism

  2012influential citation
• Management of Symptoms in Children With Autism Spectrum Disorders: A Comprehensive Review of Pharmacologic and Complementary-Alternative Medicine Treatments

  2011cites this paper
• La disfunzione delle modalità di espressione del dolore come possibile causa di comportamenti problema nel paziente portatore di autismo Dysfunction of the modalities of pain expression as a possible cause of problem behaviours in the patient with autism

  2011cites this paper
• Treatment of comorbid anxiety and autism spectrum disorders.

  2011cites this paper
• Autism-spectrum disorders are one of the leading causes of lifetime developmental disability ( Fombonne

  2010cites this paper
• Pharmacological management of core and comorbid symptoms in autism-spectrum disorder

  2010cites this paper
• Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta).

  2009cites this paper
• Influence of the 5-HTTLPR polymorphism and environmental risk factors in a Brazilian sample of patients with autism spectrum disorders.

  2009cites this paper
• Retrial of Selective Serotonin Reuptake Inhibitors in Children with Pervasive Developmental Disorders: A Retrospective Chart Review

  2009cites this paper
• Autism Spectrum Disorders: Pharmacotherapy for Challenging Behaviors

  2008cites this paper
• Pharmacological Treatment Options for Autism Spectrum Disorders in Children and Adolescents

  2008cites this paper
• Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

  2008cites this paper
• Preclinical Animal Models of Autistic Spectrum Disorders (ASD)

  2008cites this paper
• The use of pharmaceuticals in the comprehensive treatment of children with autism spectrum disorders

  2008influential citation
• Brain Norepinephrine: The locus coeruleus and regulation of behavioral flexibility and attention: clinical implications

  2007cites this paper
• Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios.

  2007cites this paper
• Early pharmacological treatment of autism: a rationale for developmental treatment.

  2007cites this paper
• [Psychopharmacology of autistic disorders].

  2007cites this paper
• Tratamiento farmacológico de conductas patológicas asociadas con el autismo y otros trastornos relacionados

  2007cites this paper
• Recent advances in the pharmacological treatment of pervasive developmental disorders

  2007cites this paper
• The status of pharmacotherapy for autism spectrum disorders

  2007cites this paper
• Is obsessive-compulsive disorder an anxiety disorder?

  2006cites this paper
• Evaluation of recent patent applications for the diagnosis and treatment of autism and pervasive developmental disorders

  2006cites this paper
• Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms.

  2006cites this paper
• A heterogeneity-based genome search meta-analysis for autism-spectrum disorders

  2006cites this paper
• An update on pharmacologic treatments for autism spectrum disorders.

  2006cites this paper
• The Case for the OCD Spectrum

  2005cites this paper
• Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders

  2005cites this paper
• Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.

  2005cites this paper
• Advances in Drug Treatments for Children and Adolescents with Autism and Other Pervasive Developmental Disorders

  2005cites this paper
• Autism spectrum disorders: emerging pharmacotherapy

  2005cites this paper
• Pharmacotherapy in Autism and Related Disorders.

  2005cites this paper
• Psychopharmacology of Autism Spectrum Disorders

  2005cites this paper
• Autism: A Unique Type of Mercury Poisoning

  2004cites this paper
• Serotonin and brain development.

  2004cites this paper
• Pharmacotherapy of Pervasive Developmental Disorders in Children and Adolescents

  2004cites this paper
• Venlafaxine has modest effects in autistic children

  2004cites this paper
• Selective serotonin reuptake inhibitor-related extrapyramidal symptoms in autistic children: a case series.

  2004cites this paper
• Autismo: estado del arte

  2003cites this paper
• Treatment of movement disorders in autism spectrum disorders

  2003cites this paper
• Etiological, diagnostic and treatment conundrum

  2003cites this paper
• Antidepressants and anticonvulsants/mood stabilizers in the treatment of autism

  2003cites this paper
• Asperger syndrome: to be or not to be?

  2003cites this paper
• Use of Citalopram in Pervasive Developmental Disorders

  2003cites this paper
• Targeted treatments for symptom domains in child and adolescent autism.

  2003cites this paper
• Pervasive developmental disorders. Etiological, diagnostic and treatment conundrum.

  2003cites this paper
• Motor activity measured by actometry in neuropsychiatric disorders

  2002cites this paper
• Psychopharmacologic Treatment Studies in Autism

  2002cites this paper
• Brain Perfusion in Autism Varies with Age

  2002cites this paper
• [Selective serotonin reuptake inhibitors and newer antidepressive substances in child and adolescent psychiatry].

  2002cites this paper
• Depression in Persons with Autism: Implications for Research and Clinical Care

  2002cites this paper
• Recent advances in the pharmacotherapy of autism

  2002cites this paper
• Is autism partly a consolidation disorder?

  2002cites this paper
• The pathophysiology and treatment of autism

  2001cites this paper
• [Evaluated treatment approaches in child and adolescent psychiatry I].

  2001cites this paper
• Pharmacotherapeutic management of autism

  2001cites this paper
• Pharmacotherapy of Autism: A Review and Clinical Approach

  2001cites this paper
• Use of venlafaxine in children and adolescents: A review of current literature

  2000cites this paper